Aramis Biotechnologies is a Canadian company founded in 2023 and based in Quebec City, specializing in the production of innovative vaccines in plants.
Benefiting from a unique technology derived from 20 years of research and development, we are committed to shaping a future in which biotechnology sustainably meets global human health needs.
By joining forces with our team of shareholder-employees, we are committed to developing innovative vaccines and fostering a culture of solidarity and responsibility.
Following an initial startup phase, we will soon welcome new team members to successfully carry out our mission! Follow our page to discover future job opportunities.
For more information on our terms of use, visit our Community Guidelines: https://bit.ly/3NmxabB
Company Details
- Employees
- 68
- Founded
- -
- Address
- 2552 Boulevard Du Parc-Technologique, Québec,quebec G1p 4s6,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Biotechnology, Vaccines, Pandemic prepardness, Plant-based, Biomanufacturing, Préparation pandémique, Biofabrication.
- HQ
- Québec, Quebec
Aramis Biotechnologies Questions
Aramis Biotechnologies's website is http://www.aramisbiotechnologies.com
Aramis Biotechnologies's LinkedIn profile is https://ca.linkedin.com/company/aramisbiotechnologies
Aramis Biotechnologies has
68 employees.
View email and phone details for 68
employees at Aramis Biotechnologies.
Aramis Biotechnologies's industry is
Biotechnology Research
Aramis Biotechnologies's top competitors are
Aramis Biosciences,
Saguaro Biosciences,
Medicago Group,
Jamp Pharma Group,
Biodextris,
Transbiotech,
Feldan Therapeutics ǀ Feldan Thérapeutiques,
Linearis,
9bio Therapeutics,
Biotwin.
Aramis Biotechnologies's categories are Biotechnology Research
Aramis Biotechnologies's founding year is 2023
